December 16th, 2025
It aims to develop the first treatment based on mRNA therapy to boost the efficacy of immunotherapy for this type of tumour. The new company, a spin-off of the Hospital del Mar Research Institute Barcelona, plans to launch its first human clinical trial in 2028 to validate the safety of this approach. The project is led by Drs. Toni Celià-Terrassa and Joan Albanell, pioneers in the development of nanotherapies designed to transform tumours that are resistant to immunotherapy into tumours that are vulnerable to treatment.
December 16th, 2025
These are some of the conclusions of the report "Working on digital platforms: What do we know about health and safety?", a joint study by UPF and the Hospital del Mar Research Institute Barcelona, within the framework of the international project GIG-OSH, which has collected data from seven European countries.
December 12th, 2025
Having a higher proportion of fatty acids in the blood from a healthy diet reduces the risk of suffering from this type of stroke by 14%. The researchers have established an index that measures more reliably than other systems used the quality of fats in the diet of the studied individuals. The work is published in the European Stroke Journal. Blood fat levels can be calculated from a simple blood test. This opens the door to its application in clinical practice.
Read more sobre "New tool designed to predict the risk of ischemic stroke from blood fats"
Parc Salut Mar
Passeig Marítim 25-29 Barcelona 08003
See location on Google maps
Phone: 93 248 30 00 · Fax: 93 248 32 54
Information request
© 2006 - 2025 Hospital del Mar · Legal notice and Privacy Police | Cookie Policy | Accessibility
